INVA  valuation analysis

Name: Innoviva, Inc
Description: Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Apr 28, 2021
Market cap: $1.33B (1178th)
Sales(TTM): $343.63M (1276th)
Earnings(TTM): $253.09M (580th)

FFER: 0.54*
Actual price: $13.09
* Earnings were reported Jul 27, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
Innoviva, Inc
"Biotechnology" industry
Sales / MarketCap
Innoviva, Inc
"Biotechnology" industry
Book / MarketCap
Innoviva, Inc
"Biotechnology" industry
Equity / Assets
Innoviva, Inc
"Biotechnology" industry